Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT02453893
Eligibility Criteria:
Inclusion Criteria:
* men and women aged 18 to 65 years with schizophrenia;
* PANSS total score of at least 70 at screening and baseline;
* at least 2 more than 4 points in 7 of PANSS-P;
* informed consent.
Exclusion Criteria:
* allergy with iloperidone or risperidone;
* psychotic symptoms failing to improve after sufficient exposure to 2 antipsychotic treatment;
* any other primary Axis 1 psychiatric diagnosis;
* a history of alcohol or drug dependence in recent 1 year;
* at imminent risk of harm to self or others;
* systolic blood pressure≤90mmHg。
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02453893
Study Brief:
Protocol Section:
NCT02453893